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Abstract:
Introduction: Infection with all serotypes of dengue virus (DV) results in augmented antigen presentation by MHC class I 
molecules. However, the upregulation of immunoproteasome subunits only results from infection with two serotypes. This study 
aims to elucidate changes in the expression of immunoproteasome subunits resulting from infection with DV, particularly DV 
serotype 2 (DV2). Methods: HepG2 cells were grown in various culture milieu. Total cellular RNA and proteins were extracted 
and quantified. Results: Results demonstrated sequestration of immunoproteasome subunits LMP2 and LMP7 in DV2-infected 
cells. Conclusions: This study provides insights into the mechanisms underlying immune evasion by DV.
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Dengue is considered the most important arboviral disease 
globally. Hundreds of millions of infections occur annually 
worldwide, with approximately 75% of cases being endemic 
to Asia-Pacific1. The dengue virus (DV) belongs to the genus 
Flavivirus. Infection with all four DV serotypes elicits an 
increase in cell surface expression of major histocompatibility 
complex (MHC) class I molecules, similar to that observed in 
cells infected with the Japanese Encephalitis virus and West 
Nile virus2-3. In addition, the antigen presentation machinery 
(APM) has also been shown to be affected by DV infection, 
specifically at the proteasomal level3. 
In order to escape the host’s immune response, viruses 
develop unique mechanisms to hijack the APM. The 
upregulation of MHC molecules in DV-infected cells does 
not appear to stimulate cytolysis by patrolling immune cells4. 
Expression of immunoproteasome subunits low molecular 
weight polypeptide-2 (LMP2) and low molecular weight 
polypeptide-7 (LMP7) is pivotal for eliciting an immune 
response. The expression of these two proteins in DV-infected 
cells, as well as in those expressing DV non-structural proteins, 
has been found to be dysregulated3-4. The present study aimed 
to investigate the effects of DV2 infection on LMP2 and LMP7 
expression in human HepG2 cells using YK73, which has been 
shown to act as an antiviral agent against DV5. 
HepG2 and Vero cell lines were obtained from the American 
Type Culture Collection (ATCC, USA). Dengue virus was 
isolated from a patient with dengue, and the presence of serotype 
2 was confirmed by reverse transcription polymerase chain 
reaction (RT-PCR)3 and sequencing (ABI, USA). Virus stock 
titer was determined via plaque assay, as previously described3.
A preformed monolayer of HepG2 cells was infected 
with DV2 at a multiplicity of infection (m.o.i) of one. Media 
containing DV2 was aspirated after two hours of incubation at 
37°C with humidified 5% CO2 and cells were rinsed with saline 
buffer. Culture medium, with or without 5µg/ml of antivirus 
YK735, was added to the infected cells and further incubated 
for an additional 48 hours. The antiviral compound YK73 has 
a maximum non-toxic dose (MNTD) of 25µg/ml and a 90% 
efficiency in inhibiting viral replication at a concentration of 
5µg/ml5. 
Cells were harvested 48 hours after post-infection 
using trypsin-ethylenediaminetetraacetic acid (EDTA), and 
ribonucleic acid (RNA) was isolated using the RNeasy mini 
kit (Qiagen, Germany) according to the manufacturer’s 
instructions. Then, 600ng of purified RNA was reverse-
transcribed into double stranded complimentary DNA (cDNA) 
using high-capacity RNA-to-cDNA kit (ABI, USA). The 
genes were quantified by real time quantitative PCR (RT-
qPCR) using the following TaqMan assays (ABI, USA): 
LMP2 (HS00160610_m1), LMP7 (HS00544760_g1), human 
leukocyte antigen type-A (HLA-A) (HS01058806_g1), 
and human leukocyte antigen type-B (HLA-B) (forward: 
5′-agccccgcttcatctcagt-3′, reverse 5′-cgctgtcgaacctcacgga-3′ 
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FIGURE 1. Gene expression profiles of LMP2, LMP7, HLA-A, and HLA-B. HepG2 cells were cultured under three different conditions: I) infected with 
mock infection media (negative control), II) infected with DV2, and III) infected with DV2 and treated with antiviral agent YK73. Cells were incubated for 48 
hours; then, total RNA was extracted and RT-qPCR was performed. Average expression of three independent experiments (n = 3) are presented. Error bars are 
expressed as standard deviation. Values with different symbols are significantly different (at p < 0.05) between groups. DV2: dengue virus type 2; HLA-A: human 
leukocyte antigen type A; HLA-B: human leukocyte antigen type B; LMP2: low molecular weight polypeptide-2; LMP7: low molecular weight polypeptide-7; 
RT-qPCR: real time quantitative polymerase chain reaction; RNA: ribonucleic acid.
and probe NEDtacgtggacgacaccaMGBNFQ-3′). The expression 
levels of all four genes were normalized against that of the 
housekeeping gene GAPDH (4326317E).
LMP2 and LMP7 proteins were visualized via western blot 
using the following antibodies: anti-proteasome 20S LMP2 
antibody ab3328 (Abcam, USA), anti-proteasome 20S LMP7 
antibody (Abcam, USA), anti-beta actin antibody (Santa Cruz 
Biotechnology Inc. USA), goat anti-mouse immunoglobulin 
G type 1 conjugated with horseradish peroxidase (IgG1-HRP) 
antibody (Santa Cruz Biotechnology Inc. USA), and Anti-rabbit 
immunoglobulin G conjugated with horseradish peroxidase (IgG-
HRP) antibody (CST, Germany). Briefly, intracellular proteins 
were extracted using cell lysis buffer and quantitated with Bradford 
reagent. Next, 80µg of protein was separated on a 12% acrylamide 
gel and transferred onto a nitrocellulose blotting membrane (PALL, 
USA). The membranes were blocked with 5% skimmed milk 
(Bio Rad, USA) in tris-buffered saline with Tween 20 (TBST) 
solution prior to incubation with primary antibodies. Subsequently, 
membranes were washed with TBST and further incubated with 
a secondary antibody. Bands on the developed membranes were 
analyzed using Image-J software (http://rsbweb.nih.gov/ij/).
Results are expressed as means ± standard deviation. 
Comparisons between groups were made using the Mann-
Whitney U-test with the statistical software package Statistical 
Package for the Social Sciences (SPSS) version 17.0 software 
for Windows (IBM, USA). 
The expression of immunoproteasome subunits LMP2 and 
LMP7 has been reported to exhibit contrasting profiles when 
cells are infected by different DV serotypes3: cells infected by 
either DV2 or DV4 demonstrated increased expression of these 
genes compared with uninfected cells, while cells infected by 
DV1 and DV3 exhibited no significant difference in LMP2 
expression and reduced expression of LMP7 compared with 
uninfected cells, respectively.
In this study, LMP2 and LMP7 expression in cells following 
treatment with antiviral agent YK73 was investigated5. The 
expression of LMP2 following antiviral treatment was found 
to be comparable to that in untreated cells; YK73-treated DV2-
infected cells demonstrated a 1.2 fold difference (p = 0.487) 
compared with untreated DV2-infected cells, while YK73-
treated DV2-infected cells demonstrated a 2.4 fold difference 
(p = 0.037) compared with uninfected cells. DV2-infected cells 
demonstrated only a two-fold increase (p = 0.037) relative to 
uninfected cells (Figure 1). 
Interestingly, a 2.8-fold (p = 0.037) and a 1.5-fold 
(p = 0.037) increase in LMP7 expression was observed in 
YK73-treated DV2-infected cells and untreated DV2-infected 
cells, respectively, in comparison with uninfected cells. 
Additionally, an approximately 2-fold increase (p = 0.037) in 
LMP7 expression was observed between the YK73-treated and 
untreated DV2-infected cells. 
Notably, the expression of MHC class I molecules was 
significantly increased in YK73-treated and untreated DV2-
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FIGURE 2. Protein expression of LMP2 and LMP7 following antiviral treatment. HepG2 cells were infected with DV2, supplemented with or without the 
antiviral compound, and incubated for 48 hours. Then, cells were harvested and protein lysate was subjected to western blot. A. Western blot of LMP2, LMP7, 
and β actin. B. The densitometry-quantified intensity of LMP2 and LMP7 bands normalized against that of β actin. Average expression determined by three 
independent experiments (n = 3) is presented. Error bars are expressed as standard deviation. Values with different symbols are significantly different at p < 0.05 
between the groups. DV2: dengue virus type 2; LMP2: low molecular weight polypeptide-2; LMP7: low molecular weight polypeptide-7. 
A
B
infected cells relative to uninfected cells. The HLA-A molecule 
presentation was approximately 1.5-fold higher (p = 0.037) in 
both YK73-treated and untreated DV2-infected cells compared 
with that in uninfected cells, independently. Similarly, HLA-B 
displayed an approximately two-fold increase (p=0.037) in 
expression in both YK73-treated and untreated DV2-infected 
cells relative to uninfected cells, respectively. These findings 
strongly suggest that MHC class I cell surface protein expression 
remains enhanced despite antiviral treatment.
In order to determine whether immunoproteasome subunit 
LMP2 and LMP7 profiles are congruent with the enhanced 
transcription levels observed upon antiviral treatment, 
western blot was conducted to compare these protein levels 
in YK73-treated and untreated DV2-infected cells (Figure 2). 
The expression of LMP7 was markedly increased in YK73-
treated DV2-infected cells (approximately 2.5-fold higher, 
p = 0.037). As anticipated, there was only a slight increase 
(~1.3-fold change, p = 0.034) in the expression of the LMP2 
subunit in YK73-treated DV2-infected cells. These findings 
clearly indicate that DV2 plays an active role in regulating the 
production of the immunoproteasome subunits. 
The proteasome is a multi-catalytic proteinase complex 
that degrades longer peptides into peptides of ~8-10 amino 
acids in length in the cytosol. Instead of acting on ‘old’ 
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proteins, these multi-subunit proteasome complexes degrade 
defective ribosomal translational products6. Antigenic 
proteins are processed by the APM, almost immediately after 
synthesis, via the transformation of the proteasome into the 
immunoproteasome; this enables rapid generation of the host 
immune response. It is notable that modulation of LMP2 and 
LMP7 expression was found to affect the efficiency of APM7. 
Additionally, a study by Khu et. al. demonstrated the role 
of the NS3 protein in downregulating LMP7 in the hepatitis 
C virus (HCV), another member of the genus Flavivirus8. 
Similar to the previous report3, this study also demonstrated 
elevation of both LMP2 and LMP7 expression during DV2 
infection. Moreover, the increase in gene expression was 
more pronounced upon administration of antiviral treatment 
to DV2-infected cells. This finding clearly demonstrates the 
subversion of immunoproteasome subunit expression, despite 
the augmentation of these subunits during DV2 infection relative 
to that in uninfected cells. It is plausible that the virulence 
of the present DV2 serotype led to higher expression of 
immunoproteasome subunits in comparison to that on infection 
with other DV serotypes. Nevertheless, the results strongly 
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FIGURE 3. Putative effect of antivirus YK73 on the transformation of the proteasome into the immunoproteasome in DV2-infected cells. Active 
replication of DV2 prevents efficient transformation of the immunoproteasome by limiting the transcription of both LMP2 and LMP7 genes. The absence of the 
immunoproteasome results in impaired generation of antigenic peptides, which leads to poor surface presentation of the antigen epitopes. Conversely, increased 
expression of both LMP2 and LMP7 was observed when virus replication was impeded by the antiviral compound YK73. This finding may indicate the recovery 
of the host response, which enables the transformation of the immunoproteasome. DV2: dengue virus type 2; LMP2: low molecular weight polypeptide-2; 
LMP7: low molecular weight polypeptide-7.
suggest that DV2 NS2B-NS3 plays a pivotal role in suppressing 
the expression of immunoproteasome subunits during infection.
In conclusion, this study provides evidence for, and elucidates 
the mechanisms underlying, the suppression of immunoproteasome 
subunit expression by DV. This conclusion was particularly 
evident when the expression of LMP7 was intensified subsequent 
to antiviral treatment. Suppression of LMP2 and LMP7 
expression may consequently prevent the transformation of the 
immunoproteasome9. As a result, the constitutive proteasomes 
available were unable to generate antigenic peptides efficiently. DV-
infected cells were considered to ultimately present ‘self’ peptides 
as a result of crippled antigen processing9, despite the observed 
augmentation in MHC class I expression3 (Figure 3). The antiviral 
treatment is shown to reduce viral replication with simultaneous 
reduction in the efficiency of manipulation of the host immune 
response by the virus. This phenomenon may indicate the recovery 
of appropriate host response, thus allowing the transformation of 
the immunoproteasome. Further in-depth study is warranted in 
order to elucidate the relationship between the antiviral compound, 
dengue infection, and the expression profiles of immunoproteasome 
subunits.
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